Stock listing
NASDAQ:IMGN ImmunoGen Inc Stock
Follow ImmunoGen Inc into a list and get an email when it puts out news.
Last close · NASDAQ:IMGN
$31.23 USD
Close on Feb 9, 2024 · No longer trades
- Lowest – highest close
- $0.844 – $43.81 USDSince Nov 17, 1989 · lowest Dec 24, 1997 · highest Nov 8, 2000
Delisted NASDAQ:IMGN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:IMGN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
ImmunoGen Inc on 6ix
- Calls
- 11 calls with a replay · 11 with a transcript · latest Nov 2, 2023
- Decks
- 8 decks · latest Jan 9, 2023
Events
| Call | When | Status |
|---|---|---|
| ImmunoGen (IMGN) Q3 2023 Earnings Call | Thu, Nov 02, 2023 · 8:00 AM ET | Replay |
| ImmunoGen (IMGN) Q2 2023 Earnings Call | Mon, Jul 31, 2023 · 8:00 AM ET | Replay |
| ImmunoGen (IMGN) Q1 2023 Earnings Call | Fri, Apr 28, 2023 · 8:00 AM ET | Replay |
| ImmunoGen (IMGN) Q3 2022 Earnings Call | Fri, Nov 04, 2022 · 8:00 AM ET | Replay |
| ImmunoGen (IMGN) Q2 2022 Earnings Call | Fri, Jul 29, 2022 · 8:30 AM ET | Replay |
| ImmunoGen (IMGN) Q1 2022 Earnings Call | Fri, May 06, 2022 · 8:00 AM ET | Replay |
| ImmunoGen (IMGN) Q4 2021 Earnings Call | Fri, Feb 25, 2022 · 8:00 AM ET | Replay |
| ImmunoGen (IMGN) Q3 2021 Earnings Call | Fri, Oct 29, 2021 · 8:00 AM ET | Replay |
| ImmunoGen (IMGN) Q2 2021 Earnings Call | Fri, Jul 30, 2021 · 8:00 AM ET | Replay |
| ImmunoGen (IMGN) Q1 2021 Earnings Call | Mon, May 10, 2021 · 8:00 AM ET | Replay |
All 11 calls
| Call | When | Status |
|---|---|---|
| ImmunoGen (IMGN) Q3 2020 Earnings Call | Fri, Nov 06, 2020 · 8:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| JP Morgan Healthcare Conference 2023 | Conference | 31 slides | Jan 9, 2023 |
| JP Morgan Healthcare Conference 2022 | Conference | 31 slides | Jan 10, 2022 |
| J.P. Morgan Healthcare Conference 2021 | Conference | 24 slides | Jan 11, 2021 |
| Technical Presentation (December 2020) | Technical | 17 slides | Dec 7, 2020 |
| Investor Presentation (January 2020) | Investor deck | 23 slides | Jan 13, 2020 |
| Technical Presentation (September 2019) | Technical | 24 slides | Sep 30, 2019 |
| Corporate Update (May 2018) | Corporate update | 11 slides | May 17, 2018 |
| FY2016 Earnings Presentation | Earnings | 22 slides | Aug 4, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mark Alan Goldberg Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); Audentes Therapeutics Inc (Director · Dec 11, 2017 – Jan 15, 2020 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 9, 2017 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); Aceragen Inc. (Director · Jan 7, 2014 – Jun 23, 2022 · Past); Synageva BioPharma Corp (EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past) | Director · Nov 8, 2011 – Feb 12, 2024 · Past |
| Mark Enyedy Other companies: Charles River Laboratories International, Inc. (Director · Since at least May 20, 2025); BioMarin Pharmaceutical Inc. (Director · Since at least Dec 27, 2023); LogicBio Therapeutics Inc (Director · Mar 17, 2020 – Nov 16, 2022 · Past); Akebia Therapeutics, Inc. (Director · Dec 12, 2018 – Jun 5, 2020 · Past); Keryx Biopharmaceuticals Inc (Director · Jun 30, 2018 – Dec 12, 2018 · Past) | CHIEF EXECUTIVE OFFICER, Director · Feb 15, 2018 – Feb 12, 2024 · Past |
| Stuart Arbuckle Other companies: Praxis Precision Medicines, Inc. (Director · Since at least Jan 8, 2026); Alnylam Pharmaceuticals, Inc. (Director · Since at least Jan 5, 2026); Rhythm Pharmaceuticals, Inc. (Director · Since at least Jul 23, 2019); Vertex Pharmaceuticals Incorporated (EVP, COO · Since at least May 25, 2016); Dare Bioscience, Inc. (Director · Jun 22, 2016 – Jan 3, 2017 · Past) | Director · Jan 23, 2018 – Feb 12, 2024 · Past |
| Dean Mitchell Other companies: Praxis Precision Medicines, Inc. (Chairman of the Board · Since at least Oct 15, 2020); Theravance Biopharma, Inc. (Director · Since at least Apr 30, 2019); Kinnate Biopharma Inc (Director · Dec 2, 2020 – Apr 3, 2024 · Past); Precigen, Inc. (Director · Mar 8, 2020 – Mar 14, 2024 · Past) | Director · Mar 31, 2019 – Feb 12, 2024 · Past |
| Nicole Onetto Other companies: Bolt Biotherapeutics, Inc. (Director · Since at least Dec 14, 2021); Viracta Therapeutics Inc (Director · Mar 26, 2021 – Jun 9, 2022 · Past); Sunesis Pharmaceuticals Inc (Director · Sep 17, 2019 – Jun 30, 2020 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Jun 11, 2019 · Past) | Director · Nov 12, 2013 – Nov 10, 2015 · Past |
| Isabel Kalofonos Other companies: CG Oncology, Inc. (Chief Commercial Officer · Since at least Oct 13, 2026); Crinetics Pharmaceuticals, Inc. (Chief Commercial Officer · Since at least Dec 16, 2024) | SVP & CHIEF COMMERCIAL OFFICER · Apr 24, 2023 – Feb 12, 2024 · Past |
| Richard J Gregory Other companies: ProMIS Neurosciences Inc. (Director · Jul 7, 2022 – Jul 7, 2022 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 15, 2022 · Past) | Executive VP & CSO · Jan 5, 2015 – Feb 22, 2019 · Past |
| Anna Berkenblit Other companies: Surrozen, Inc. (Director · Since at least Jun 7, 2022) | SVP & CHIEF MEDICAL OFFICER · May 20, 2022 – Jun 30, 2023 · Past |
| David Brannon Johnston Other companies: AVEO Pharmaceuticals Inc (Chief Financial Officer · Mar 11, 2010 – Oct 2, 2013 · Past) | Chief Financial Officer · Dec 30, 2013 – Jun 6, 2018 · Past |
| Stacy Ann Coen Other companies: FibroBiologics, Inc. (Director · Since at least Jan 24, 2024) | SVP & CHIEF BUSINESS OFFICER · May 20, 2022 – Feb 12, 2024 · Past |
All 15 people
| Person | Seat |
|---|---|
| Stephen C McCluski Other companies: Monro, Inc. (Director · Since at least Aug 6, 2021) | Director · Jun 16, 2021 – Feb 12, 2024 · Past |
| Suzanne Cadden Other companies: Novelion Therapeutics Inc (SVP, Development · Sep 14, 2011 – Sep 14, 2011 · Past) | VP, Regulatory & Quality · Dec 17, 2009 – Dec 17, 2009 · Past |
| Craig Barrows | Executive VP, General Counsel · Jul 20, 2012 – Feb 24, 2020 · Past |
| David G Foster | V.P.-Fin., Prin. Acctg. Off. · Sep 13, 2018 – Dec 31, 2020 · Past |
| John Tagliamonte | VP, Business Development · Nov 27, 2007 – Jun 11, 2008 · Past |
Log in to ask 6ix AI your own questions about ImmunoGen Inc.